Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.27M Buy
7,532
+6
+0.1% +$1.05K 0.02% 263
2025
Q4
$1.23M Sell
7,526
-80
-1% -$12K 0.02% 264
2025
Q3
$1.03M Buy
7,606
+1,255
+20% +$178K 0.02% 291
2025
Q2
$823K Buy
6,351
+2,315
+57% +$271K 0.01% 304
2025
Q1
$486K Buy
4,036
+86
+2% +$11.1K 0.01% 363
2024
Q4
$461K Buy
3,950
+2,444
+162% +$352K 0.01% 365
2024
Q3
$226K Sell
1,506
-30
-2% -$4.51K ﹤0.01% 448
2024
Q2
$243K Hold
1,536
﹤0.01% 426
2024
Q1
$304K Sell
1,536
-6
-0.4% -$1.1K 0.01% 395
2023
Q4
$268K Sell
1,542
-77
-5% -$12.2K 0.01% 412
2023
Q3
$253K Hold
1,619
0.01% 405
2023
Q2
$265K Buy
1,619
+88
+6% +$12.8K 0.01% 402
2023
Q1
$236K Buy
+1,531
New +$244K 0.01% 411

Other funds holding NUE

Glenview Trust's NUE Position: Q1 2026 in Review

Glenview Trust increased its Nucor (NUE) stake by 0.08% in Q1 2026, buying an estimated $1.05K and bringing the position to 7,532 shares worth $1.27M. The position accounts for 0.02% of the portfolio, ranked #263.

Glenview Trust first reported a position in NUE in Q1 2023 and has held it in 13 quarters since. 1,371 funds tracked by Wall St. Rank hold NUE as of Q1 2026.

  • Glenview Trust held 7,532 shares of Nucor worth $1.27M as of Q1 2026.
  • Glenview Trust bought 6 Nucor shares in Q1 2026, an estimated $1.05K.
  • Nucor made up 0.02% of Glenview Trust's portfolio in Q1 2026, its #263 holding.
  • Glenview Trust first reported a position in Nucor in Q1 2023 and has held it in 13 quarters since.
  • 1,371 funds tracked by Wall St. Rank held Nucor as of Q1 2026.

Based on Glenview Trust's 13F filing for Q1 2026, filed 8 May 2026.